Adalimumab in patients with vision-threatening uveitis: real-world clinical experience

OBJECTIVES: Biologics are rapidly emerging as an effective vision saving addition to systemic uveitis therapy. The aim of this multicentre retrospective study is to review the outcomes of a large group of patients treated with adalimumab. METHODS: A retrospective chart review of patients with refrac...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang Lee Say, Timothy Lee, Yang, Verlyn, Fingret, Jacob M, Zagora, Sophia, Symes, Richard, Younan, Christine, Cornish, Elisa Eleanor, Verma, Nitin, Sammel, Anthony, Wakefield, Denis, Speden, Deborah, McCluskey, Peter J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Uveitis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8477319/
https://www.ncbi.nlm.nih.gov/pubmed/34632076
http://dx.doi.org/10.1136/bmjophth-2021-000819

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8477319/
https://www.ncbi.nlm.nih.gov/pubmed/34632076
http://dx.doi.org/10.1136/bmjophth-2021-000819

Ejemplares similares